INTRODUCTION {#sec1-1}
============

Ocular hypotony the incidence of which has increased following the advent of anti-metabolites,\[[@ref1][@ref2][@ref3]\] is a potentially devastating complication of filtering surgery in glaucoma patients. If left untreated, associated complications of hypotony including maculopathy and corneal decompensation may become vision threatening. Other complications consist of progressive cataract, inflammation, ciliochoroidal effusion or hemorrhage, extensive retinal detachment, optic nerve edema, and even phthisis with significant visual loss.\[[@ref4]\]

Current surgical interventions for management of post-filtering hypotony mostly aim to reduce filtration from the bleb site. Resuturing of the scleral flap is advised at the early stages of ocular hypotony,\[[@ref5]\] while more aggressive treatments might be considered necessary when the risk of hypotony maculopathy is judged to be high. A myriad of different interventions have been suggested by different authors;\[[@ref6][@ref7][@ref8][@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref20][@ref21][@ref22][@ref23][@ref24][@ref25][@ref26][@ref27][@ref28][@ref29]\] most of them seem to induce inflammation at the surgical site and bleb.

Among the current theories, the role of induced inflammation at the trabeculectomy site seems to be more intriguing, which is believed to decrease aqueous leak by scar formation at the trabeculectomy site.\[[@ref30][@ref31][@ref32][@ref33]\] Theoretically, any kind of intraocular surgery might induce intraocular inflammation and our previous observations after phacoemulsification in previously filtered eyes showed intraocular pressure (IOP) rise in some patients. Based on this assumption and due to the relatively high rate of development or progression of cataracts in patients undergoing filtering surgery, we decided to perform a preliminary longitudinal study on the efficacy and safety of cataract extraction as the initial intervention for management of patients with post-filtering surgery ocular hypotony.

METHODS {#sec1-2}
=======

In this prospective interventional case series, we recruited 21 consecutive eyes of 21 patients with an established diagnosis of post-filtering surgery ocular hypotony with or without maculopathy over a 1-year period at Farabi Eye Hospital, a University-based tertiary care center. The study was approved by the Ethics Committee of Tehran University of Medical Sciences and adhered to the tenets of the Declaration of Helsinki. Written informed consent was taken from all patients.

All patients had previously undergone a fornix-based trabeculectomy with intraoperative application of mitomycin C for the management of glaucoma and were diagnosed with persistent ocular hypotony (IOP \< 6 mmHg) for more than 4 months. All patients also had visually significant cataracts.

Exclusion criteria were history of eye surgery other than filtering surgery, bleb leak, visually insignificant cataracts and reluctance for phacoemulsification as a potential treatment modality to treat ocular hypotony.

Baseline characteristics and demographic data including age, gender, time interval between filtering surgery and phacoemulsification, and type of glaucoma were recorded. Patients then received a comprehensive ophthalmologic examination including measurement of best-corrected visual acuity (BCVA) in LogMAR units, slit lamp examination, applanation tonometry (Goldmann applanation tonometer), keratometry and fundus examination.

Hypotony maculopathy was defined as a decrease of at least two lines in BCVA from baseline, retinal striae, and macular edema in the setting of low IOP. Filtering blebs were categorized as diffuse and low lying with normal conjunctival vasculature (Type I), and as localized and avascular or ischemic (Type II). Pre-and postoperative anterior chamber depth (ACD) was measured using an optical coherence biometer (IOLMaster v. 3, Zeiss Meditec, CA, USA).

All procedures were performed by a single experienced glaucoma surgeon (GF) using the same surgical technique (temporal clear corneal incision phacoemulsification with in-the-bag implantation of a foldable intraocular lens) in all cases. Postoperatively, patients received topical steroid and antibiotic eye drops; the antibiotic drop was prescribed for 1-week, the steroid drop was used every 2 h for the 1^st^ week and then every 4, 6, 8, and 12 h during the 2^nd^ to 5^th^ weeks after surgery. Follow-up sessions were scheduled on the 1^st^ day, 1^st^ week, and 1^st^, 3^rd^ and 6^th^ months postoperatively. The results of the 6^th^ month and last session follow-up were noted and considered for final analysis.

Success at 6 months and last visit was defined as complete if IOP was 6 to 21 mmHg without any glaucoma medication and qualified if IOP was within the same range with the use of glaucoma medications. The outcome was categorized as a failure in case of persistent hypotony or IOP \> 21 mmHg despite maximum tolerated medical therapy.

Statistical analysis was performed using SPSS for windows version 17 (SPSS Inc., Chicago, IL, USA). All data were represented as mean ± standard deviation. Due to the relatively small sample size (and also skewed distribution of pre- and postsurgical IOP), we used Wilcoxon one-sample nonparametric test for evaluation of continuous variables. Spearman\'s correlation coefficient was used to evaluate the correlation between continuous variables. The contingency coefficient was used to evaluate the correlation between the two categorical variables. For all measurements, a two-tailed test was used, and P\<0.05 was considered significant.

RESULTS {#sec1-3}
=======

A total of 21 eyes of 21 patients with cataract and post-filtering ocular hypotony were enrolled in the study. All procedures were performed without significant intraoperative complications, and the postoperative course was uneventful in all cases. Two cases were excluded from the study due to incomplete follow-up; the 19 cases that completed at least 6 months\' follow-up were considered for final analysis.

Demographics and baseline characteristics of the patients are provided in [Table 1](#T1){ref-type="table"}. Mean age was 61.7 ± 10.3 (range, 48--85) years and 12 patients (63%) were male. The mean time interval time between filtering surgery and phacoemulsification was 7.1 ± 2.2 (range, 4--12) months and mean follow-up following cataract surgery was 10.6 ± 3.6 (range, 6--18) months. None of the patients were on glaucoma medication. Filtering blebs were categorized as Type I in 13 cases (68%) and as Type II in 6 cases (32%).

###### 

Patient\'s demographics and characteristics (*n*=19)

![](JOVR-10-385-g001)

Mean baseline IOP was 2.9 ± 1.4 (range: 0--5) mmHg which was increased to 8.8 ± 4.7 (range: 4--20, *n* = 19) mmHg and to 10.4 ± 4.8 (range: 4--19, *n* = 15) mmHg at 6 months (*P* \< 0.001) and at last visit (*P* = 0.001), respectively. The trend of IOP changes following surgery is shown in [Figure 1](#F1){ref-type="fig"}. Mean IOP change was + 7.7 ± 8.8 (range: 0 to + 30, *n* = 19) mmHg, +5.9 ± 5.3 (range: −1 to + 19, *n* = 19) mmHg and + 7.3 ± 5.8 (range: −1 to + 18, *n* = 15) mmHg at postoperative 1 and 6 months, and at last visit, respectively. There was a significant correlation between postoperative IOP rise and the presence of Type I filtering blebs (r = 0.735, *P* \< 0.001).

![Intraocular pressure trend during the follow-up period (SE, standard error).](JOVR-10-385-g002){#F1}

Postoperative IOP change at all follow-up time points was not correlated with patient age, time interval between filtering surgery and phacoemulsification, baseline IOP, baseline ACD and IOP on postoperative day 1. After 6 months, hypotony was resolved in 13 cases (68%), while 6 cases (32%) showed persistent hypotony. Three cases (16%) showed filtering bleb failure with dramatic IOP rise, all around the first postoperative month, and needed two glaucoma medications for IOP control. None of these eyes required additional glaucoma surgery. Clinical features of these three cases are given in [Table 2](#T2){ref-type="table"}. Success at 6 months (*n* = 19) was complete in 10 cases (52%) qualified in 3 cases (16%) while 6 cases (31%) were categorized as failures. Corresponding figures at last visit (*n* = 15) were 8 (53%), 3 (20%) and 4 (27%) cases, respectively.

###### 

Characteristics of three patients who ended up with bleb failure

![](JOVR-10-385-g003)

At baseline, choroidal effusion was present in 7 cases (37%) which resolved in all but one case (5%) by 6 months. ACD increased from 2.48 ± 0.59 (range: 1.2--3.3) mm at baseline to 3.43 ± 0.36 (range: 2.3--3.8) mm at 6 months (*P* \< 0.001). Retinal folds characteristic of hypotony maculopathy could be detected in 7 cases (37%) at baseline. Due to hazy media, it was not possible to perform an exact fundus examination in another 5 patients (26%). At postoperative month six, 4 cases (21%) showed persistent hypotony maculopathy.

Mean LogMAR BCVA improved from 0.95 ± 0.2 (range, 0.7--1.3) at baseline to 0.5 ± 0.16 (range: 0.2--0.8) at 6 months (*P* \< 0.001). Mean cylindrical refractive error changed from 2.73 ± 0.97 (range: 1--4.75) diopters at baseline to 1.17 ± 0.44 (range: 0.5--2.25) diopters at 6 months (*P* \< 0.001).

DISCUSSION {#sec1-4}
==========

The results of our study indicate that cataract surgery can induce IOP rise in patients with post-filtering surgery hypotony and cataracts. Excluding 3 cases that demonstrated bleb failure, we achieved a 52% complete success rate at last visit to treat ocular hypotony by performing phacoemulsification; however, including these 3 cases we were able to treat hypotony in 68% of our patients by performing phacoemulsification alone. Furthermore, after 6 months, choroidal effusion and hypotony maculopathy were resolved in 95% and 79% of cases, respectively.

Controversy still exists on the possible effect of cataract extraction on IOP in patients with a history of trabeculectomy. There are numerous controversial studies in the literature discussing either the effect of surgical method (phacoemulsification vs. extracapsular cataract extraction \[ECCE\]) or the timing of surgery, i.e., simultaneous phacoemulsification-trabeculectomy or phacoemulsification at a given time interval from trabeculectomy.\[[@ref30][@ref32][@ref34][@ref35][@ref36][@ref37][@ref38][@ref39][@ref40][@ref41][@ref42][@ref43][@ref44]\]

Earlier studies on intracapsular cataract surgery or ECCE believed that these procedures may increase IOP in patients with functioning filtering blebs.\[[@ref32][@ref37][@ref39][@ref42]\] After the introduction of phacoemulsification, Caprioli et al\[[@ref45]\] showed that although it may cause a transient elevation in IOP in previously trabeculectomized eyes, no significant difference in IOP control occurs after 1-year. Casson et al\[[@ref36]\] also performed phacoemulsification with an interval of at least 3 months from trabeculectomy in glaucoma patients and found no statistical difference between pre-and postoperative IOP taken 2 years after the surgery. Some other studies have also confirmed the findings by Caprioli et al and Casson et al.\[[@ref37][@ref43][@ref46]\] On the other hand, other studies have reported that when phacoemulsification is performed at a time interval from trabeculectomy, a statistically significant rise in IOP should be expected in glaucoma patients.\[[@ref38][@ref39][@ref42][@ref44][@ref47][@ref48][@ref49]\] Furthermore, certain factors such as the time interval between trabeculectomy and cataract surgery\[[@ref38][@ref41]\] and IOP level before cataract surgery\[[@ref40][@ref44][@ref49]\] seem to affect the degree of IOP rise after cataract surgery in trabeculetomized eyes.

Also of interest are the controversial ideas on comparing the effect of surgical method (phacoemulsification or ECCE) on mean IOP of post-filtering surgery eyes.\[[@ref36][@ref37][@ref39][@ref42][@ref47]\] Halikiopoulos et al believe that both techniques increase IOP in the long-term to the same extent;\[[@ref47]\] while Casson et al have claimed that ECCE, but not phacoemulsification, causes IOP rise in previously filtered eyes.\[[@ref36]\] Some other studies have found that both methods increase IOP in trabeculectomized eyes; however, phacoemulsification had less effect on postoperative IOP control than did ECCE.\[[@ref37][@ref39][@ref42]\]

The results of the present study support studies that showed IOP rise following phacoemulsification in post-filtering patients. We observed that following phacoemulsification at least 4 months after trabeculectomy, mean IOP increased by about 5.89 mm Hg after 6 months (*P* \< 0.0001). This effect was also seen to be persistent at last follow-up in all cases. It was also observed in our case series that, after 6 months of follow-up, ocular hypotony was completely resolved in 13 patients (68%), while 6 patients (32%) still presented with ocular hypotony, among which 4 patients showed persistent hypotony maculopathy.

The main mechanism explaining increased IOP after cataract surgery in post-filtering ocular hypotony might be surgically induced inflammatory reaction along with scar tissue formation leading to decreased filtration of aqueous through the filtering bleb.\[[@ref30][@ref31][@ref32][@ref33]\] Considering the total success rate of 68% in our study, it sounds that the induced inflammation is an unpredictable phenomenon which cannot delimit bleb function in all patients. Furthermore, due to the short-term follow-up of our study, we cannot make a comment on the long lasting effect of the inflammatory reaction on overfiltration.

In one study evaluating ultrasound biomicroscopic features of blebs before and after phacoemulsification,\[[@ref49]\] the route under the scleral flap became narrower and intrableb reflectivity increased after cataract surgery, these alterations were not statistically significant though. Therefore, it can be inferred that the principal location of inflammation and scar formation after cataract surgery are conjunctival-scleral and/or at the scleral flap interface.

Bleb failure occurred in 16% of our patients after cataract extraction, all in cases with diffuse and low-lying filtering blebs \[[Table 2](#T2){ref-type="table"}\]. Diffuse blebs have normal vasculature as compared to localized cystic ones, and it can be assumed that they may also have a more normal cell population as well. Therefore, it would not be surprising that these cells are capable of promoting inflammation and scar formation after an insult (such as phacoemulsification) in contrast to thin cystic blebs which may have a smaller number of pro-inflammatory cells. This theory may be evaluated in future studies by measuring the concentration of cytokines and cell populations.

Mean BCVA improved dramatically after 6 months in our patients which could not be exclusively attributed to the cataract extraction; it seems that this improvement occurred in part due to correction of hypotony maculopathy and reduction in cylindrical refractive error in our patients.

Although we cannot compare our results with previous studies examining different strategies to treat ocular hypotony, in the current study phacoemulsification cataract surgery was able to increase mean IOP by 5.9 mmHg after 6 months and by 7.4 mmHg IOP at final follow-up. The 68% success rate for treating ocular hypotony in the current study is higher than that of currently suggested treatment modalities.\[[@ref6][@ref7][@ref8][@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref20][@ref21][@ref22][@ref23][@ref24][@ref25][@ref26][@ref27][@ref28][@ref29][@ref50]\] This study has some limitations such as relatively small sample size, absence of a control group, relatively short-term follow-up, and lack of supporting pathobiological evidence.

In summary, cataract surgery seems to be a promising strategy for management of post-filtering surgery ocular hypotony. Although the preliminary results of the current study have been intriguing, the future direction should be toward designing multicenter controlled trials with higher sample sizes and long-term follow-up to confirm the reliability, safety and efficacy of this intervention.
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